TARDBP and amyotrophic lateral sclerosis: Its discovery in the inclusions of diseases that are as widespread as ALS and FTLD-U dates back to 2006 [1,2], i.e. very recently relative to aggregated proteins of similarly widespread neurodegenerative conditions, witnessing the difficulty to characterize the histological, structural, and morphological characteristics of TDP-43 aggregates.